Commentary

Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations

Young AH, Abdelghani M, Juruena MF, Nikolova VL, Nilforooshan R

Neuropsychiatric Disease and Treatment 2023, 19:433-441

Published Date: 24 February 2023